Give Today

Reducing HIV
transmission
between mothers
and children

4.5 million people accessing lifesaving HIV/AIDS treatments

Global Health

Although treatments exist for infectious diseases such as HIV/AIDS, malaria, and tuberculosis, the developing world has had limited access to these treatments because of their high cost. A decade ago, only 200,000 people in developing countries were receiving treatment, with medicines that could cost over $10,000 per person annually. At its most basic level, this problem was one of economics: the market for these medicines was disorganized and operating at a low-volume, high-cost model. And developing health systems lacked the infrastructure to diagnose and treat patients properly.

By collaborating with manufacturers on the supply side and governments on the demand side – and transitioning the market to a high-volume, low-cost model – we have reduced the cost of key drugs and enabled millions of people to receive lifesaving treatment. We've also applied this model to address treatments for malaria and tuberculosis, to improve access to diagnostics, and to scale up the delivery of lifesaving vaccines. We continue to work to economize and improve care in developing countries, with an ultimate goal of fundamentally changing the economics of global health and building health systems that are self-sustaining.

Programs

Recent News